Atlas Trials

A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)

Clinical trial NCT04734405 · UNKNOWN

Trial details

NCT number
NCT04734405
Sponsor
ProFem GmbH
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Recurrent Vulvovaginal Candidiasis
Start date
2019-10-01
Primary completion
2022-11-01
Enrollment
432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.